Induction of tolerogenic DCs: 'You are what you eat'

Trends in Immunology

Volumn 24, Issue 12, 2003, Pages 646-651

  Mahnke, Karsten ^a   Knop, Juergen ^a   Enk, Alexander H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CD205 ANTIGEN; CD206 ANTIGEN; FC RECEPTOR; INTEGRIN; LECTIN; LYMPHOCYTE ANTIGEN RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; APOPTOSIS; CELL MATURATION; CROSS TOLERANCE; DENDRITIC CELL; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0344440959     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2003.09.012     Document Type: Review

References (60)

1. Trombetta E.S., , et al. Activation of lysosomal function during dendritic cell maturation. Science. 299:2003;1400-1403.
2. Inaba K., , et al. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:2000;927-936.
3. Shortman K., Heath W.R. Immunity or tolerance? That is the question for dendritic cells. Nat. Immunol. 2:2001;988-989.
4. Jonuleit H., , et al. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213-1222.
5. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood. 101:2003;4862-4869.
6. Bonifaz L., , et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8(+) T cell tolerance. J. Exp. Med. 196:2002;1627-1638.
7. Hawiger D., , et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:2001;769-779.
8. Cambi A., , et al. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 33:2003;532-538.
9. Engering A., , et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168:2002;2118-2126.
10. Geijtenbeek T.B., , et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197:2003;7-17.
11. Tassaneetrithep B., , et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197:2003;823-829.
12. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1998;1359-1368.
13. Morelli A.E., , et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood. 101:2003;611-620.
14. Sedlik C., , et al. A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation. J. Immunol. 170:2003;846-852.
15. Leteux C., , et al. The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood group Lewis(a) and Lewis(x) types in addition to the sulfated N-glycans of lutropin. J. Exp. Med. 191:2000;1117-1126.
16. Linehan S.A., , et al. Endogenous ligands of carbohydrate recognition domains of the mannose receptor in murine macrophages, endothelial cells and secretory cells; potential relevance to inflammation and immunity. Eur. J. Immunol. 31:2001;1857-1866.
17. Engering A., , et al. Immune escape through C-type lectins on dendritic cells. Trends Immunol. 23:2002;480-485.
18. Drickamer K. C-type lectin-like domains. Curr. Opin. Struct. Biol. 9:1999;585-590.
19. Dzionek A., , et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194:2001;1823-1834.
20. Tan M.C., , et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27:1997;2426-2435.
21. Engering A.J., , et al. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27:1997;2417-2425.
22. Mahnke K., , et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151:2000;673-684.
23. Wilson N.S., , et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood. 102:2003;2187-2194.
24. Jonuleit H., , et al. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213-1222.
25. Dhodapkar M.V., Steinman R.M. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood. 100:2002;174-177.
26. Suess G., Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1996;1789-1796.
27. Akbari O., , et al. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:2001;725-731.
28. - dendritic cells regulate T cell responses. J. Immunol. 166:2001;7042-7052.
29. Belz G.T., , et al. The CD8α (+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196:2002;1099-1104.
30. Kronin V., , et al. Differential effect of CD8(+) and CD8(-) dendritic cells in the stimulation of secondary CD4(+) T cells. Int. Immunol. 13:2001;465-473.
31. Kronin V., , et al. DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses. Int. Immunol. 12:2000;731-735.
32. Kronin V., , et al. Are CD8+ dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Int. Immunol. 9:1997;1061-1064.
33. Stupack D.G., Cheresh D.A. Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 115:2002;3729-3738.
34. Larsson M., , et al. Dendritic cells resurrect antigens from dead cells. Trends Immunol. 22:2001;141-148.
35. Nauta A.J., , et al. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 24:2003;148-154.
36. Verbovetski I., , et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 196:2002;1553-1561.
37. Albert M.L., , et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998;86-89.
38. Liu K., , et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196:2002;1091-1097.
39. Kurts C., , et al. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J. Exp. Med. 186:1997;239-245.
40. Huang F.P., , et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:2000;435-444.
41. Kurts C., , et al. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166:2001;1439-1442.
42. Inaba K., , et al. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186:1997;665-672.
43. Urban B.C., , et al. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. U. S. A. 98:2001;8750-8755.
44. Ravetch J.V., Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 19:2001;275-290.
45. Bolland S., , et al. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity. 8:1998;509-516.
46. Kanazawa N., , et al. Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor gamma chain. J. Biol. Chem. 278:2003;32645-32652.
47. Regnault A., , et al. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:1999;371-380.
48. + CTL responses in vivo. J. Immunol. 168:2002;2240-2246.
49. Legge K.L., , et al. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196:2002;217-227.
50. Kalergis A.M., Ravetch J.V. Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells. J. Exp. Med. 195:2002;1653-1659.
51. Bolland S., Ravetch J.V. Spontaneous autoimmune disease in Fc(γ)RIIB-deficient mice results from strain-specific epistasis. Immunity. 13:2000;277-285.
52. Nakamura A., , et al. Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J. Exp. Med. 191:2000;899-906.
53. Pritchard N.R., , et al. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII. Curr. Biol. 10:2000;227-230.
54. Jiang Y., , et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics. 51:2000;429-435.
55. Mahnke K., , et al. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80:2002;477-483.
56. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23:2002;445-449.
57. + T cell tolerance. Immunity. 18:2003;713-720.
58. Sauter B., , et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:2000;423-434.
59. Steinbrink K., , et al. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood. 93:1999;1634-1642.
60. Menges M., , et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195:2002;15-21.